Christina A. Nelson
, Shubhayu Saha, Kiersten J. Kugeler, Mark J. Delorey, Manjunath B. Shankar, Alison Hinckley, and Paul S. Mead
Figure 2. Trends of annual incidence of Lyme disease in MarketScan compared with trends in incidence from US surveillance, 2005–2010. Incidence is per 100,000 persons. Trends in interannual incidence fluctuation did not differ significantly between MarketScan and US surveillance (χ2 test, p = 0.81). *Cases reported through the National Notifiable Diseases Surveillance System. During 2005–2007, incidence was calculated as the number of confirmed cases/100,000 persons; during 2008–2010, incidence was calculated as the number of confirmed and probable cases/100,000 persons. US 2010 Census population estimates were used as the denominator for surveillance data incidence calculations.